Cargando…
_version_ 1782416538177896448
author Proskurina, Anastasia S.
Gvozdeva, Tatiana S.
Alyamkina, Ekaterina A.
Dolgova, Evgenia V.
Orishchenko, Konstantin E.
Nikolin, Valeriy P.
Popova, Nelly A.
Sidorov, Sergey V.
Chernykh, Elena R.
Ostanin, Alexandr A.
Leplina, Olga Y.
Dvornichenko, Victoria V.
Ponomarenko, Dmitriy M.
Soldatova, Galina S.
Varaksin, Nikolay A.
Ryabicheva, Tatiana G.
Uchakin, Peter N.
Zagrebelniy, Stanislav N.
Rogachev, Vladimir A.
Bogachev, Sergey S.
Shurdov, Mikhail A.
author_facet Proskurina, Anastasia S.
Gvozdeva, Tatiana S.
Alyamkina, Ekaterina A.
Dolgova, Evgenia V.
Orishchenko, Konstantin E.
Nikolin, Valeriy P.
Popova, Nelly A.
Sidorov, Sergey V.
Chernykh, Elena R.
Ostanin, Alexandr A.
Leplina, Olga Y.
Dvornichenko, Victoria V.
Ponomarenko, Dmitriy M.
Soldatova, Galina S.
Varaksin, Nikolay A.
Ryabicheva, Tatiana G.
Uchakin, Peter N.
Zagrebelniy, Stanislav N.
Rogachev, Vladimir A.
Bogachev, Sergey S.
Shurdov, Mikhail A.
author_sort Proskurina, Anastasia S.
collection PubMed
description
format Online
Article
Text
id pubmed-4757989
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47579892016-02-19 Erratum to: Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer Proskurina, Anastasia S. Gvozdeva, Tatiana S. Alyamkina, Ekaterina A. Dolgova, Evgenia V. Orishchenko, Konstantin E. Nikolin, Valeriy P. Popova, Nelly A. Sidorov, Sergey V. Chernykh, Elena R. Ostanin, Alexandr A. Leplina, Olga Y. Dvornichenko, Victoria V. Ponomarenko, Dmitriy M. Soldatova, Galina S. Varaksin, Nikolay A. Ryabicheva, Tatiana G. Uchakin, Peter N. Zagrebelniy, Stanislav N. Rogachev, Vladimir A. Bogachev, Sergey S. Shurdov, Mikhail A. BMC Cancer Erratum BioMed Central 2016-02-17 /pmc/articles/PMC4757989/ /pubmed/26887451 http://dx.doi.org/10.1186/s12885-016-2163-y Text en © Proskurina et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Erratum
Proskurina, Anastasia S.
Gvozdeva, Tatiana S.
Alyamkina, Ekaterina A.
Dolgova, Evgenia V.
Orishchenko, Konstantin E.
Nikolin, Valeriy P.
Popova, Nelly A.
Sidorov, Sergey V.
Chernykh, Elena R.
Ostanin, Alexandr A.
Leplina, Olga Y.
Dvornichenko, Victoria V.
Ponomarenko, Dmitriy M.
Soldatova, Galina S.
Varaksin, Nikolay A.
Ryabicheva, Tatiana G.
Uchakin, Peter N.
Zagrebelniy, Stanislav N.
Rogachev, Vladimir A.
Bogachev, Sergey S.
Shurdov, Mikhail A.
Erratum to: Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer
title Erratum to: Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer
title_full Erratum to: Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer
title_fullStr Erratum to: Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer
title_full_unstemmed Erratum to: Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer
title_short Erratum to: Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer
title_sort erratum to: results of multicenter double-blind placebo-controlled phase ii clinical trial of panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage ii-iv breast cancer
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757989/
https://www.ncbi.nlm.nih.gov/pubmed/26887451
http://dx.doi.org/10.1186/s12885-016-2163-y
work_keys_str_mv AT proskurinaanastasias erratumtoresultsofmulticenterdoubleblindplacebocontrolledphaseiiclinicaltrialofpanagenpreparationtoevaluateitsleukostimulatoryactivityandformationoftheadaptiveimmuneresponseinpatientswithstageiiivbreastcancer
AT gvozdevatatianas erratumtoresultsofmulticenterdoubleblindplacebocontrolledphaseiiclinicaltrialofpanagenpreparationtoevaluateitsleukostimulatoryactivityandformationoftheadaptiveimmuneresponseinpatientswithstageiiivbreastcancer
AT alyamkinaekaterinaa erratumtoresultsofmulticenterdoubleblindplacebocontrolledphaseiiclinicaltrialofpanagenpreparationtoevaluateitsleukostimulatoryactivityandformationoftheadaptiveimmuneresponseinpatientswithstageiiivbreastcancer
AT dolgovaevgeniav erratumtoresultsofmulticenterdoubleblindplacebocontrolledphaseiiclinicaltrialofpanagenpreparationtoevaluateitsleukostimulatoryactivityandformationoftheadaptiveimmuneresponseinpatientswithstageiiivbreastcancer
AT orishchenkokonstantine erratumtoresultsofmulticenterdoubleblindplacebocontrolledphaseiiclinicaltrialofpanagenpreparationtoevaluateitsleukostimulatoryactivityandformationoftheadaptiveimmuneresponseinpatientswithstageiiivbreastcancer
AT nikolinvaleriyp erratumtoresultsofmulticenterdoubleblindplacebocontrolledphaseiiclinicaltrialofpanagenpreparationtoevaluateitsleukostimulatoryactivityandformationoftheadaptiveimmuneresponseinpatientswithstageiiivbreastcancer
AT popovanellya erratumtoresultsofmulticenterdoubleblindplacebocontrolledphaseiiclinicaltrialofpanagenpreparationtoevaluateitsleukostimulatoryactivityandformationoftheadaptiveimmuneresponseinpatientswithstageiiivbreastcancer
AT sidorovsergeyv erratumtoresultsofmulticenterdoubleblindplacebocontrolledphaseiiclinicaltrialofpanagenpreparationtoevaluateitsleukostimulatoryactivityandformationoftheadaptiveimmuneresponseinpatientswithstageiiivbreastcancer
AT chernykhelenar erratumtoresultsofmulticenterdoubleblindplacebocontrolledphaseiiclinicaltrialofpanagenpreparationtoevaluateitsleukostimulatoryactivityandformationoftheadaptiveimmuneresponseinpatientswithstageiiivbreastcancer
AT ostaninalexandra erratumtoresultsofmulticenterdoubleblindplacebocontrolledphaseiiclinicaltrialofpanagenpreparationtoevaluateitsleukostimulatoryactivityandformationoftheadaptiveimmuneresponseinpatientswithstageiiivbreastcancer
AT leplinaolgay erratumtoresultsofmulticenterdoubleblindplacebocontrolledphaseiiclinicaltrialofpanagenpreparationtoevaluateitsleukostimulatoryactivityandformationoftheadaptiveimmuneresponseinpatientswithstageiiivbreastcancer
AT dvornichenkovictoriav erratumtoresultsofmulticenterdoubleblindplacebocontrolledphaseiiclinicaltrialofpanagenpreparationtoevaluateitsleukostimulatoryactivityandformationoftheadaptiveimmuneresponseinpatientswithstageiiivbreastcancer
AT ponomarenkodmitriym erratumtoresultsofmulticenterdoubleblindplacebocontrolledphaseiiclinicaltrialofpanagenpreparationtoevaluateitsleukostimulatoryactivityandformationoftheadaptiveimmuneresponseinpatientswithstageiiivbreastcancer
AT soldatovagalinas erratumtoresultsofmulticenterdoubleblindplacebocontrolledphaseiiclinicaltrialofpanagenpreparationtoevaluateitsleukostimulatoryactivityandformationoftheadaptiveimmuneresponseinpatientswithstageiiivbreastcancer
AT varaksinnikolaya erratumtoresultsofmulticenterdoubleblindplacebocontrolledphaseiiclinicaltrialofpanagenpreparationtoevaluateitsleukostimulatoryactivityandformationoftheadaptiveimmuneresponseinpatientswithstageiiivbreastcancer
AT ryabichevatatianag erratumtoresultsofmulticenterdoubleblindplacebocontrolledphaseiiclinicaltrialofpanagenpreparationtoevaluateitsleukostimulatoryactivityandformationoftheadaptiveimmuneresponseinpatientswithstageiiivbreastcancer
AT uchakinpetern erratumtoresultsofmulticenterdoubleblindplacebocontrolledphaseiiclinicaltrialofpanagenpreparationtoevaluateitsleukostimulatoryactivityandformationoftheadaptiveimmuneresponseinpatientswithstageiiivbreastcancer
AT zagrebelniystanislavn erratumtoresultsofmulticenterdoubleblindplacebocontrolledphaseiiclinicaltrialofpanagenpreparationtoevaluateitsleukostimulatoryactivityandformationoftheadaptiveimmuneresponseinpatientswithstageiiivbreastcancer
AT rogachevvladimira erratumtoresultsofmulticenterdoubleblindplacebocontrolledphaseiiclinicaltrialofpanagenpreparationtoevaluateitsleukostimulatoryactivityandformationoftheadaptiveimmuneresponseinpatientswithstageiiivbreastcancer
AT bogachevsergeys erratumtoresultsofmulticenterdoubleblindplacebocontrolledphaseiiclinicaltrialofpanagenpreparationtoevaluateitsleukostimulatoryactivityandformationoftheadaptiveimmuneresponseinpatientswithstageiiivbreastcancer
AT shurdovmikhaila erratumtoresultsofmulticenterdoubleblindplacebocontrolledphaseiiclinicaltrialofpanagenpreparationtoevaluateitsleukostimulatoryactivityandformationoftheadaptiveimmuneresponseinpatientswithstageiiivbreastcancer